pharmaphorum

NOVEMBER 23, 2020

He joined Johnson & Johnson in 2001 as Director Corporate Communications. In 2006 he joined the Janssen teams working in Infectious Diseases where he helped to maintain and enhance the company’s relationships with the HIV Patient Community. About the author. In that function, he initially worked in the field of oncology.

Communication 128

Communication Documentation Vaccines 128

pharmaphorum

DECEMBER 10, 2020

Independent communications agency OVID Health has appointed Niall Dickson, professor David Salisbury and Athena Lamnisos as senior counsel, providing strategic advice and thought leadership across several projects involving healthcare and pharma clients. He was made a Companion of the Order of the Bath in 2001.

Communication 52

Communication Immunization Vaccines 52

pharmaphorum

APRIL 14, 2022

In a world of a million messages, should authenticity be the common thread tying all pharma communications and marketing activities together? Authentic, knowledgeable communications designed and executed by authentic, knowledgeable professionals is the key to pharma’s success in today’s media landscape. Authentic communications.

Communication 52

Communication Vaccines 52

ISPE

OCTOBER 26, 2022

ATMP facilities are different from conventional pharmaceutical facilities that process other traditional modalities, such as vaccines and monoclonal antibodies (mAbs), and often require heightened segregation and smaller footprints. Viral antigen vaccines. For example: Live vaccine manufacturing. Complete Data Gathering.

Vaccines 97

Vaccines Compounding Documentation FDA 97

The Checkup by Singlecare

MARCH 28, 2024

In a 2001 study that compared azithromycin to amoxicillin for the treatment of chlamydia in pregnancy, cure rates of both drugs were high. This can be done in several ways, including abstaining from sexual activity, vaccination, and mutual monogamy. Many STDs can be cured with the proper treatment.

Dosage 97

Dosage FDA Communication Labelling 97

Pharmaceutical Technology

FEBRUARY 20, 2023

Hans Bunschoten: Viroclinics was founded in 2001, spun out of a university setting. The capabilities of Viroclinics and DDL allowed us to rapidly test repurposed drugs, new vaccines and antiviral solutions for the prevention and treatment of patients affected by COVID-19 in 2020. Can you tell us a little bit about Viroclinics-DDL?

Vaccines 52

Vaccines Communication Immunization 52